Overview

Phase II HDM-SPIRE Safety and Efficacy Study

Status:
Completed

Trial end date:
2017-04-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the treatment effect of three treatment regimens of HDM-SPIRE vs placebo and to evaluates the treatment effect of HDM-SPIRE on symptoms, rescue medication usage, Quality of Life and Sleep Quality

Phase:

Phase 2

Details

Lead Sponsor:

Circassia Limited

Collaborator:

Quintiles, Inc.